天智航收盘上涨1.58%，最新市净率4.43，总市值52.24亿元

Core Insights - Tianzhihang Medical Technology Co., Ltd. is a leading enterprise in the orthopedic surgical robot industry in China, focusing on the research, production, sales, and service of orthopedic surgical navigation robots [1] - As of the latest quarterly report for Q3 2024, the company reported a revenue of 92.12 million yuan, a year-on-year decrease of 31.08%, and a net profit loss of approximately 76.17 million yuan, a year-on-year decline of 5.68% [1] - The company's gross profit margin stands at 67.45%, indicating a strong profitability despite the revenue decline [1] Company Overview - Tianzhihang is recognized as one of the top 10 robotics companies in China and serves as a key research center for national and local engineering in medical robotics [1] - The company has 33 institutional investors holding a total of 2.435 million shares, with a market value of 2.4 million yuan [1] Financial Metrics - The company's current price-to-earnings (P/E) ratio is -42.43, indicating negative earnings, while the industry average P/E is 46.15 [2] - The price-to-book (P/B) ratio is 4.43, with a total market capitalization of 5.224 billion yuan [2] - Comparatively, the industry median P/B ratio is 2.31, suggesting that Tianzhihang is valued higher than the industry average [2]